Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive CancerAlison M. Schram, Alexander Drilon, Sai‐Hong Ignatius Ou et al.|New England Journal of Medicine|2025Cited by 104
GPT-4 for Information Retrieval and Comparison of Medical Oncology GuidelinesDyke Ferber, Jakob Nikolas Kather, Isabella C. Wiest et al.|NEJM AI|2024Cited by 82
PPD01.02 Repotrectinib in Patients With ROS1 Fusion-Positive (ROS1+) NSCLC: Update From the Pivotal Phase 1/2 TRIDENT-1 TrialAlexander Drilon, Byoung Chul Cho, D. Ross Camidge et al.|Journal of Thoracic Oncology|2024Cited by 0